Immune-Mediated Adverse Effects of Checkpoint Inhibitors: A Clinical Experience
, , y
18 jun 2022
Acerca de este artículo
Categoría del artículo: Short Communication
Publicado en línea: 18 jun 2022
Páginas: 84 - 86
Recibido: 25 abr 2022
Aceptado: 10 may 2022
DOI: https://doi.org/10.2478/afpuc-2022-0006
Palabras clave
© 2022 Jan Juřica et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Juřica, Jan
Faculty of Medicine, Department of Pharmacology, Masaryk UniversityBrno, Czech Republic
Masaryk Memorial Cancer InstituteBrno, Czech Republic
Faculty of Pharmacy, Department of Pharmacology and Toxicology, Masaryk UniversityBrno, Czech Republic
Goněc, Roman
Masaryk Memorial Cancer InstituteBrno, Czech Republic
Bártová, Adela
Faculty of Medicine, Department of Pharmacology, Masaryk UniversityBrno, Czech Republic
Gregorová, Jana
Faculty of Medicine, Department of Biochemistry, Masaryk UniversityBrno, Czech Republic